Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
Afula, 18101, Israel
NCT Number: NCT00456729
Infants should receive prophylacatic iron supplementation since age 4 months till one year. Patients suffering from malabsorption, mainly Giardia infestation may develop iron deficiency resistent to further iron treatment. The purpose of this study is to assess the incidence of malabsorption in those infants and to examine the results of empiric treatment with metronidazole.
Looking for future studies?
Notify Me6 month–4 year
All sexes
Interventional
Not applicable
Afula, 18101, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
HaEmek Medical Center, Israel
Other
Malabsorption as a Cause of Iron Treatment Failure in Infants - A Clinical Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07631312
Anemia, Anemia, Hypochromic
Atlanta, Georgia, United States
View Trial DetailsNCT05990166
Anemia, Anemia, Hypochromic
Ottawa, Ontario, Canada
View Trial DetailsNCT06773975
Anaemia, Anemia
Accra, Greater Accra Region, Ghana
View Trial DetailsNCT02233764
Iron Deficiencies, Iron Deficiency
Bengaluru, Karnataka, India
View Trial Details